VoxNeuro has joined a pilot study led by St. Joseph’s Healthcare Hamilton which is designed to identify biomarkers of bipolar disorder.
The company’s Cognitive Health Assessments ™, a lab-developed tool which provides objective data of a patient’s brain function, will be used alongside blood tests and various behavioural and clinical assessments for bipolar disorder. The objective of the study is to create a bank of potential biomarkers for the different stages of the disease.